CDEK
← All trials

NCT06851832

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 16, 2025
Primary completion
Sep 16, 2026
Completion date
Sep 16, 2028
First posted
Feb 28, 2025
Last posted
Mar 3, 2025
Enrollment
960
Arms / groups
6 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.